Dihydroxyaluminum aminoacetate manufacturers

Filters

Filters

Filters , active

Country of origin : China
None products found

aspirin + magnesium carbonate + dihydroxyaluminum aminoacetate

Tablets 81 mg + 22 mg + 11 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
China
Manufacturer #39060
China-based biotechnology company supplying pharmaceutical-grade natural plant extracts, bioactive ingredients, and specialty raw materials for Rx and nutraceutical applications. Produces solid and liquid ingredient forms for pharmaceutical and health supplement manufacturers across domestic and international markets. Operates under domestic GMP standards with export supply capabilities.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

About aspirin

Aspirin manufacturers include the originator Bayer and hundreds of generic producers worldwide, with most API made in China and Europe. Aspirin (acetylsalicylic acid) is one of the oldest and most widely used medicines. At higher doses, it relieves pain, fever and inflammation. At low doses, it prevents blood clots and is used to prevent heart attacks and strokes. Pharmaceutical companies can source aspirin tablets, gastro-resistant and effervescent forms, and API through out-licensing, supply or technology transfer. Dossiers are available in EU CTD and US ANDA or OTC formats.

Aspirin key facts

Property

Aspirin

INN

Acetylsalicylic acid

Chemical name

2-acetoxybenzoic acid

Molecular formula / weight

C9H8O4 / 180.2 g/mol

CAS number

50-78-2

ATC code

N02BA01 (analgesic); B01AC06 (antiplatelet)

Drug class

NSAID; antiplatelet agent

Brand names

Aspirin, Aspirin Protect, Aspirin Cardio (Bayer); many generics

Originator

Bayer (Germany), trademark registered 1899

Dosage forms and strengths

Tablets 75, 81, 100, 300, 325 and 500 mg; gastro-resistant tablets; effervescent and chewable tablets; injectable lysine acetylsalicylate (some markets)

Indications

Pain, fever and inflammation; secondary prevention of heart attack and stroke; acute coronary syndromes

WHO Essential Medicines

Listed (as analgesic and antiplatelet)

Safety points

Gastrointestinal bleeding; Reye's syndrome risk in children and teenagers

Generic status

Off-patent; available worldwide

Aspirin manufacturers and licensing history

Bayer chemists made a pure, stable form of acetylsalicylic acid in 1897, and Bayer registered the Aspirin trademark in 1899. In many countries, "aspirin" later became a generic name, while Bayer keeps the trademark in others.

Today, aspirin is made by hundreds of companies worldwide. Most acetylsalicylic acid API is produced in China, with Bayer and other European producers also supplying large volumes. Finished products range from simple tablets to gastro-resistant, effervescent and combination products, such as fixed-dose combinations with clopidogrel or statins.

Buyers should confirm GMP status, a CEP or DMF, salicylic acid impurity limits and moisture protection in packaging before choosing a dossier partner.

Aspirin dosage forms and dossier types

Aspirin is approved in many forms. Generic aspirin manufacturers most often develop low-dose gastro-resistant tablets for heart protection and standard tablets for pain.

Form

Strengths

Typical dossier

Notes

Aspirin low-dose tablets (gastro-resistant)

75, 81, 100 mg

EU CTD; US OTC monograph

Main form for licensing; cardiovascular prevention

Aspirin analgesic tablets

300, 325, 500 mg

EU CTD; US OTC monograph

Pain and fever

Aspirin effervescent / chewable tablets

Per product

EU CTD

Faster onset

Aspirin combinations

Per product

EU CTD (fixed-dose combination)

With clopidogrel, statins, caffeine, others

Acetylsalicylic acid API

Bulk

CEP; DMF

Moisture-sensitive

Target market

Dossier format

Key requirement

European Union

EU CTD

Reference Bayer products; national procedures

United States

OTC monograph / ANDA

OTC labelling rules

Africa, Asia, Latin America

CTD / ACTD

WHO-listed medicine; zone IVb stability

Aspirin regulatory and patent status

Aspirin is off-patent and available worldwide. It is on the WHO Model List of Essential Medicines. Guidance on low-dose aspirin for primary prevention has tightened in recent years, and it is now mainly recommended for secondary prevention in people with heart disease or previous stroke. Labels warn against use in children and teenagers because of Reye's syndrome.

Aspirin mechanism of action and therapeutic use

Aspirin irreversibly blocks cyclooxygenase (COX) enzymes. At higher doses, this reduces prostaglandins and relieves pain, fever and inflammation. At low doses, it stops platelets producing thromboxane A2 for their whole lifespan, which reduces blood clotting. Aspirin is used for pain and fever, and at low doses to prevent heart attacks and strokes.

Aspirin licensing and sourcing

Aspirin suppliers and licensing partners typically offer dossier out-licensing, finished-product supply or technology transfer. Buyers usually compare GMP status (EU GMP, US FDA or WHO GMP), dossier format, API source and territory availability. Current offers and supplier contacts are listed among the aspirin manufacturers on Pipelinepharma.

Frequently asked questions about aspirin

Who are the main aspirin manufacturers? Bayer is the originator. Hundreds of generic manufacturers make aspirin worldwide, and most API is produced in China and Europe.

Is an aspirin EU CTD dossier available for licensing? Yes. Aspirin low-dose gastro-resistant and analgesic tablet dossiers in EU CTD format are widely available.

What forms and strengths of aspirin are available? Aspirin is available as 75–100 mg low-dose tablets, 300–500 mg analgesic tablets, gastro-resistant, effervescent and chewable tablets, and combinations.

What is the difference between aspirin and acetylsalicylic acid? They are the same substance. Acetylsalicylic acid is the INN, and Aspirin is Bayer's trademark, which became a generic name in many countries.

Can children take aspirin? Aspirin is generally not used in children and teenagers because of the risk of Reye's syndrome, except under medical supervision for specific conditions.

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.